OpenEvidence Secures $250M, Reaches $12B Valuation
OpenEvidence, a three-year-old healthcare AI startup founded in 2022, raised $250 million in equity financing and reached a $12 billion post-money valuation, The Information reports. The company reports annual recurring revenue above $100 million and hundreds of thousands of active users across hospitals, clinics, and individual practitioners, driven by subscription and enterprise licensing. The round will fund multimodal R&D and international expansion aimed at integrating evidence-focused AI into clinical workflows.
Key Points
- 1Raises $250 million and secures $12 billion post-money valuation, with ARR exceeding $100 million
- 2Focuses on evidence-based medical retrieval to reduce hallucinations and appeal to hospitals and clinicians
- 3Plans multimodal R&D and enterprise expansion, signaling deployable clinical tools and integration opportunities
Scoring Rationale
High valuation and revenue show major sector momentum, limited by reliance on press reporting and pending regulatory risks.
Sources
Public references used for this report.
Practice with real FinTech & Trading data
90 SQL & Python problems · 15 industry datasets
250 free problems · No credit card
See all FinTech & Trading problems